1-anilino-8-naphthalenesulfonate has been researched along with Hyperchylomicronemia Late Onset in 9 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acipimox was given at a dose of 750 mg/day for the first 6 months and 1200 mg/day for the last period." | 2.66 | Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia. ( Nikkilä, EA; Taskinen, MR, 1988) |
| "A 41-year-old woman and her 2 sons had Type V hyperlipoproteinemia." | 1.29 | Familial type V hyperlipoproteinemia with hyper-remnant-like particle-cholesterol accompanied with apolipoprotein E3/E4 phenotype. ( Mori, M; Nagai, T; Nakajima, K; Nakano, T; Saito, T; Tomizawa, T, 1996) |
| "In subjects with primary lipoprotein lipase deficiency (n = 4), apo E was confined to fractions I and III." | 1.27 | Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. ( Brown, WV; Gibson, JC; Ginsberg, HN; Kakis, G; Little, A; Paterniti, JR; Rubinstein, A, 1985) |
| "Gross hyperlipidemia revealed type V hyperlipoproteininemia, according to agarose gel electrophoretic pattern of serum lipoprotein." | 1.26 | Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes. ( Haba, T; Kawato, M; Mabuchi, H; Nakabayashi, H; Takeda, R; Tatami, R; Ueda, K, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schonfeld, G | 1 |
| Breier, C | 3 |
| Lisch, HJ | 2 |
| Drexel, H | 1 |
| Braunsteiner, H | 2 |
| Takeda, R | 1 |
| Tatami, R | 1 |
| Ueda, K | 1 |
| Haba, T | 1 |
| Kawato, M | 1 |
| Nakabayashi, H | 1 |
| Mabuchi, H | 1 |
| Nagai, T | 1 |
| Tomizawa, T | 1 |
| Saito, T | 1 |
| Nakano, T | 1 |
| Nakajima, K | 1 |
| Mori, M | 1 |
| Musliner, TA | 1 |
| Herbert, PN | 1 |
| Kingston, MJ | 1 |
| Taskinen, MR | 1 |
| Nikkilä, EA | 1 |
| Rubinstein, A | 1 |
| Gibson, JC | 1 |
| Paterniti, JR | 1 |
| Kakis, G | 1 |
| Little, A | 1 |
| Ginsberg, HN | 1 |
| Brown, WV | 1 |
1 review available for 1-anilino-8-naphthalenesulfonate and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors.
Topics: Abetalipoproteinemia; Apolipoproteins; Apoproteins; Female; Humans; Hyperlipoproteinemia Type III; H | 1984 |
1 trial available for 1-anilino-8-naphthalenesulfonate and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Effects of acipimox on serum lipids, lipoproteins and lipolytic enzymes in hypertriglyceridemia.
Topics: Adult; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Humans; Hyperlipoproteinemia | 1988 |
7 other studies available for 1-anilino-8-naphthalenesulfonate and Hyperchylomicronemia Late Onset
| Article | Year |
|---|---|
Post-heparin lipolytic activities and alterations of the chemical composition of high density lipoproteins in alcohol-induced type V hyperlipidemia.
Topics: Alcoholism; Apolipoprotein C-I; Apolipoproteins C; Heparin; Humans; Hyperlipoproteinemia Type V; Lip | 1984 |
Secondary type V hyperlipoproteinemia in an acromegalic patient without overt diabetes.
Topics: Acromegaly; Adult; Cholesterol; Growth Hormone; Hormones; Humans; Hyperlipidemias; Hyperlipoproteine | 1982 |
Familial type V hyperlipoproteinemia with hyper-remnant-like particle-cholesterol accompanied with apolipoprotein E3/E4 phenotype.
Topics: Adult; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Bezafibrate; Cholesterol; Chylomicro | 1996 |
Lipoprotein substrates of lipoprotein lipase and hepatic triacylglycerol lipase from human post-heparin plasma.
Topics: Adipose Tissue; Animals; Chylomicrons; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Typ | 1979 |
[Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease].
Topics: Adult; Alcoholism; Cholesterol; Coronary Disease; Humans; Hydrogen-Ion Concentration; Hyperlipoprote | 1986 |
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
Topics: Adult; Apolipoproteins E; Child, Preschool; Female; Heparin; Humans; Hyperlipoproteinemia Type I; Hy | 1985 |
[Lipoproteins, post-heparin lipoprotein lipase and hepatic triglyceride lipase in patients with and without severe hyperlipemia caused by alcoholism].
Topics: Adult; Aged; Alcoholism; Cholesterol; Humans; Hyperlipoproteinemia Type V; Lipase; Lipoprotein Lipas | 1985 |